High-Dose Epirubicin Is Not an Alternative to Standard-Dose Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas. A Study of the EORTC Soft Tissue and Bone Sarcoma Group
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1998.735
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 1998
Authors
Publisher
Springer Science and Business Media LLC